Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H20ClN3O2 |
InChIKeyILMHDRGZABQLEW-UHFFFAOYSA-N |
CAS Registry2613307-67-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Australia | 01 Mar 2021 |





